CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
Authors
Keywords
TNBC, CXorf61, CD8+ T cell epitope, T-cell receptor cloning, immunotherapy
Journal
Oncotarget
Volume 6, Issue 28, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-29
DOI
10.18632/oncotarget.4516

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.